Heterocyclic derivatives as opioid receptor modulators
申请人:Janssen Pharmaceutica NV
公开号:EP2275105A1
公开(公告)日:2011-01-19
This invention is directed towards compounds of formula (II) as intermediates for opioid receptor modulators, antagonists, and agonists useful for the treatment of opioid modulated disorders such as pain and gastrointestinal disorders.